The Efficacy of Botulinum Toxin, Triamcinolone or Fu's needle for the Treatment of refractory Post-Herpetic Neuralgia

Phase 1

Not yet recruiting

• Conditions: postherpetic neuralgia

• Registration Number: ITMCTR2200005993
• Lead Sponsor: Xiao Bao

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Participants were required to have a visual analogue scale (VAS) score 7 at baseline.

Exclusion Criteria

Exclusion criteria included cranial nerves involvement, severe non-PHN pain that might compromise evaluation of pain caused by PHN, and skin disorders that might impair the therapeutic technique. In addition, female patients were required not to be pregnant or lactating

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
function assessment;